News
The response of monetary gain or loss is determined by brain structure
Researchers from IDIBELL and UB describe how the reward mechanisms in humans are determined by structural properties of brain white matter Addictive behaviours
New data validate effectiveness of a new treatment for leukaemia
Published in Blood Article reference Santidrián AF* González-Gironès DM* Iglesias-Serret D* Coll-Mulet L* Cosialls AM* de Frias M* Campàs C* González-Barca E* Alonso E* Pons G Gil J*
Manel Esteller interviewed in Science Magazine
Science magazinepublishes this week in its Science Careers supplement aninterview with Manel Esteller, director of the Epigenetics and Cancer Biology at Bellvitge Biomedical Research Institute (IDIBELL). The interview, entitled “Opening New Avenues in Epigenetics Research”, is part of the publication of a special on epigenetics in the latest issue of the magazine. Science is the […]
Bellvitge University Hospital, one of the best hospitals in Spain
Iasist’s Top 20 Hospitals recognizes quality, performance and efficiency
HUBc, disigned campus of international excellence
Thus, the UB became the first and only general university of Spain which has two international excellence campuses. The UB, along with the UPC [Catalan Polithecnic University], also won this award last year with the Barcelona Knowledge Campus (BKC). HUBc Campus includes the Medicine campus of Barcelona Clinic Hospital, along with Sant Joan de Déu […]
La Marató de TV3 finance four projects involving IDIBELL researchers
Four IDIBELL researchers are involved in projects funded by La Marató de TV3 2009, dedicated to rare diseases. They are Julian Ceron, research group of chemoresistance and predictors of response and stromal tumour, Victor Volpini, research group of Neurological Disorders and Neurogenetics, David Monk, head of the group of genomic imprinting and cancer, and Ethel Queralt, head Cell Cycle Group. Julián Cerón Madrigal Victor Volpini Bertran David Monk Ethelvina Queralt Badia
Manel Esteller bestowed with the World Health Summit Award
The IDIBELL researcher receives in Berlin the World Health Summit and Pfizer Award for Innovation in Biomedical Research Manel Esteller Profile